187 related articles for article (PubMed ID: 36339241)
1. Effectiveness of international virtual training on biorisk management in the context of COVID-19.
Qasmi SA; Standley C; Mohsin S; Sarwar S; Malik L; Aziz F
Front Public Health; 2022; 10():888097. PubMed ID: 36339241
[TBL] [Abstract][Full Text] [Related]
2. A Cross-Sectional Survey to Assess Biorisk Management System in Research and Diagnostic Laboratories in Khyber Pakhtunkhwa, Pakistan.
Muhammad J; Sarwar S; Khan T; Qasmi SA; Ikram A; Ahmad G; Zahid M; Durrani RH; Ahmed F
Front Public Health; 2021; 9():766162. PubMed ID: 34976925
[TBL] [Abstract][Full Text] [Related]
3. A Mentorship Program to Develop Biorisk Manuals for Laboratories in Pakistan.
Sarwar S; Moreno MMN; Chaudhri M; Aamir UB; Ikram A
Appl Biosaf; 2022 Dec; 27(4):219-224. PubMed ID: 36761992
[TBL] [Abstract][Full Text] [Related]
4. Strengthening Biorisk Management Capacities in Burkina Faso: Contribution of the Global Health Security Agenda.
Dama E; Orelle A; Nikiema A; Mandingar PD; Naby A; Bationo GB; Kéita MS; Pierson A; Sawadogo C; Koné RG
Health Secur; 2022; 20(6):479-487. PubMed ID: 36399610
[TBL] [Abstract][Full Text] [Related]
5. Biosafety and biosecurity measures: management of biosafety level 3 facilities.
Zaki AN
Int J Antimicrob Agents; 2010 Nov; 36 Suppl 1():S70-4. PubMed ID: 20801002
[TBL] [Abstract][Full Text] [Related]
6. [Biorisk Management for Clinical Diagnostic Laboratories].
Shigematsu M
Rinsho Byori; 2016 Nov; 64(11):1279-1289. PubMed ID: 30695310
[TBL] [Abstract][Full Text] [Related]
7. Biorisk Management for SARS-CoV-2 Research in a Biosafety Level-3 Core Facility.
Joseph T; Phyu S; Se-Thoe SY; Chu JJH
Methods Mol Biol; 2022; 2452():441-464. PubMed ID: 35554920
[TBL] [Abstract][Full Text] [Related]
8. Assessment of biosafety implementation in clinical diagnostic laboratories in Pakistan during the COVID-19 pandemic.
Sarwar S; Shahzad F; Vajeeha A; Munir R; Yaqoob A; Naeem A; Sattar M; Gull S
J Biosaf Biosecur; 2022 Jun; 4(1):43-49. PubMed ID: 35072000
[TBL] [Abstract][Full Text] [Related]
9. Biorisk assessment for infrastructure & biosafety requirements for the laboratories providing coronavirus SARS-CoV-2/(COVID-19) diagnosis.
Mourya DT; Sapkal G; Yadav PD; M Belani SK; Shete A; Gupta N
Indian J Med Res; 2020 Feb & Mar; 151(2 & 3):172-176. PubMed ID: 32242878
[TBL] [Abstract][Full Text] [Related]
10. Strengthening Biorisk Management in Research Laboratories with Security-Sensitive Biological Agents Like SARS-CoV-2.
Phyu S; Joseph T; Goulart M
Methods Mol Biol; 2022; 2452():395-439. PubMed ID: 35554919
[TBL] [Abstract][Full Text] [Related]
11. Biosafety Capacity Building During the COVID-19 Pandemic: Results, Insights, and Lessons Learned from an Online Approach in the Philippines.
Cena-Navarro R; Vitor RJ; Canoy RJ; Dela Tonga A; Ulanday GE; Silva MRC; Destura RV
Appl Biosaf; 2022 Mar; 27(1):42-50. PubMed ID: 36032322
[TBL] [Abstract][Full Text] [Related]
12. Implementation of Active Learning Approach to Teach Biorisk Management and Dual-Use Research of Concern in Egypt.
Elhadidy M; El-Tholoth M; Brocard AS
Appl Biosaf; 2019 Jun; 24(2):100-110. PubMed ID: 36033939
[TBL] [Abstract][Full Text] [Related]
13. Understanding Biosafety and Biosecurity in Ukraine.
Houser RS; Koblentz GD; Lentzos F
Health Secur; 2023; 21(1):70-80. PubMed ID: 36629857
[TBL] [Abstract][Full Text] [Related]
14. Challenges in Implementing a Biorisk Management Program at Universitas Indonesia: A Checklist Tool for Biorisk Management.
Naroeni A; Bachtiar EW; Ibrahim F; Bela B; Kusminanti Y; Pujiriani I; Lestari F
Health Secur; 2016; 14(6):375-381. PubMed ID: 27830940
[TBL] [Abstract][Full Text] [Related]
15. Strengthening laboratory biosafety in Liberia during the COVID-19 pandemic: Experience from the Global Laboratory Leadership Programme.
Malik S; Taweh FM; Freeman M; Dogba JB; Gwesa GO; Tokpah M; Gbondin PP; Kohar TH; Hena JY; MaCauley JA; Pierson A; Rayfield MA; Peruski LF; Albetkova A; Balish A
One Health; 2022 Dec; 15():100442. PubMed ID: 36249991
[TBL] [Abstract][Full Text] [Related]
16. Combing pre-workshop, web-based learning and hands-on workshop as a flipped classroom clinical skill training model during the COVID-19 pandemic.
Huang TX; Kuo HH; Lo TS; Liang CC; Lin YH; Chou HH
Taiwan J Obstet Gynecol; 2022 Sep; 61(5):755-760. PubMed ID: 36088041
[TBL] [Abstract][Full Text] [Related]
17. Concepts to Bolster Biorisk Management.
Dettmann RA; Ritterson R; Lauer E; Casagrande R
Health Secur; 2022; 20(5):376-386. PubMed ID: 35997589
[TBL] [Abstract][Full Text] [Related]
18. Assessment of biorisk management systems in high containment laboratories, 18 countries in Europe, 2016 and 2017.
Appelt S; Jacob D; Rohleder AM; Bråve A; Szekely Björndal Å; Di Caro A; Grunow R;
Euro Surveill; 2020 Sep; 25(36):. PubMed ID: 32914748
[TBL] [Abstract][Full Text] [Related]
19. WHO Laboratory Biosafety Manual: A New Approach to Security.
Ficociello B; Giordano D; Incoronato F; Farinella A; Pietrangeli B
Ann Work Expo Health; 2023 Apr; 67(4):425-429. PubMed ID: 36495279
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
